Nuvasive Inc (NUVA) 46.99 $NUVA
NuVasive to Participate in Investor Event in February 2015
Marketwired - Wed Feb 04, 3:07PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive" or the "Company"
, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor event in February 2015:
NUVA: 46.99 (+0.30)
30.3% Return Seen to Date on SmarTrend NuVasive Call (NUVA)
Comtex SmarTrend(R) - Thu Jan 29, 9:42AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 7 months, NuVasive has returned 30.30% as of today's recent price of $46.47.
NUVA: 46.99 (+0.30)
Downgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Tue Jan 13, 8:34AM CST
NuVasive (NASDAQ:NUVA) was downgraded from Buy to Neutral at Summer Street today. The stock closed yesterday at $49.34 on volume of 180,000 shares, below average daily volume of 342,000. In the past 52 weeks, shares of NuVasive have traded between the current low of $0.00 and a high of $51.23 and are now at $0.00. Over the past week, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 1.6%.
NUVA: 46.99 (+0.30)
New operating chief at NuVasive
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 3:13PM CST
NUVA: 46.99 (+0.30)
NuVasive Announces Expanded Leadership Roles for Executives Pat Miles and Matt Link
Marketwired - Mon Jan 12, 3:01PM CST
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive procedural solutions for spine surgery, today announced changes to its leadership team designed to enhance the Company's organizational alignment and accelerate its market share-taking strategy in the global spine market.
NUVA: 46.99 (+0.30)
NuVasive Announces Select Preliminary Unaudited Full-Year 2014 Financial Results and 2015 Outlook
Marketwired - Mon Jan 12, 3:00PM CST
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive procedural solutions for spine surgery, today provided a business and financial performance update, including the announcement of select preliminary unaudited financial results for the full-year ended December 31, 2014 and the issuance of select performance guidance for the full-year 2015.
NUVA: 46.99 (+0.30)
Global Spinal Fixation Industry Report 2015
M2 - Mon Jan 12, 6:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/vnqxn5/global_spinal) has announced the addition of the "Global Spinal Fixation Industry Report 2015" report to their offering. The Spinal Fixation Industry industry Report is a professional and in-depth study on the current state of the Spinal Fixation Industry Industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Spinal Fixation Industry market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Spinal Fixation Industry industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on the Spinal Fixation Industry industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Spinal Fixation Industry industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Spinal Fixation Industry Overview - Spinal Fixation International and China Market Analysis - Spinal Fixation Technical Data and Manufacturing Plants Analysis - Spinal Fixation Production by Regions by Technology by Applications - Spinal Fixation Manufacturing Process and Cost Structure - 2009-2014 Spinal Fixation Productions Supply Sales Demand Market Status and Forecast - Spinal Fixation Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Spinal Fixation Marketing Channels Analysis - 2015-2020 Spinal Fixation Productions Supply Sales Demand Market Status and Forecast - Spinal Fixation Industry Development Proposals - Spinal Fixation New Project Investment Feasibility Analysis - Global and China Spinal Fixation Industry Research Conclusions Companies Mentioned - A-Spine - Aesculap - Alphatec Spine Inc. - BK Meditech - Bestbio-Technical - Bonovo - ChunLi - DePuy Spine Inc. (J&J) - Dingjian Medical Instrument - Exactech Inc. - Fule Science & Technology - IRENE(Nation Medical Group) - Jiangsu IDEAL Medical Science & Technology - Kanghui Medical (Medtronic Sofamor Danek USA) - LDR Medical - Medtronic - NuVasive Inc. - PASSmed - PW MedTech - Sintea Plustek - Stryker Spine - Trauson Holding (Stryker) - WEGO - Waston - Xingang Medical Instrument - Xinrong Best Medical Instrument - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/vn...bal_spinal
ZMH: 119.33 (+1.18), MDT: 75.26 (+0.33), EXAC: 22.33 (-0.28), NUVA: 46.99 (+0.30)
Spinal Products Firm NuVasive Ripe For Expansion
at Investor's Business Daily - Thu Jan 08, 2:17PM CST
Shares of NuVasive (NUVA) moved higher in early trading on the stock market today after the maker of spinal products received an analyst upgrade that cited its potential to grab more market share, particularly internationally. In a morning research...
LDRH: 37.73 (+1.70), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45), BAX: 70.39 (+0.31), COV: 106.71 (-1.36), EW: 134.23 (+1.89), NUVA: 46.99 (+0.30)
Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Thu Jan 08, 6:54AM CST
NuVasive (NASDAQ:NUVA) was upgraded from Sector Perform to Outperform at RBC Capital today. The stock closed yesterday at $48.49 on volume of 598,000 shares, above average daily volume of 315,000. NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
NUVA: 46.99 (+0.30)
NuVasive Has Returned 33.1% Since SmarTrend Recommendation (NUVA)
Comtex SmarTrend(R) - Wed Jan 07, 11:05AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 7 months, NuVasive has returned 33.07% as of today's recent price of $47.46.
NUVA: 46.99 (+0.30)
NuVasive to Participate in Investor Event in January 2015
Marketwired - Mon Jan 05, 3:05PM CST
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor event in January 2015:
NUVA: 46.99 (+0.30)
Shares of NUVA Up 36.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 31, 9:44AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 6 months, NuVasive has returned 36.13% as of today's recent price of $48.55.
NUVA: 46.99 (+0.30)
Use of Composites in Orthopedic Industry to Reach $596 Million by 2020
PR Newswire Europe - Wed Dec 24, 3:57AM CST
NEW YORK and LONDON, December 24, 2014 /PRNewswire/ --
SNN: 35.82 (-0.28), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), NUVA: 46.99 (+0.30), SYK: 94.51 (+1.14)
NuVasive Shares Up 26.5% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Tue Dec 16, 5:09PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 6 months, NuVasive has returned 26.54% as of today's recent price of $45.13.
NUVA: 46.99 (+0.30)
Uptrend Call Working As NuVasive Stock Rises 27.8% (NUVA)
Comtex SmarTrend(R) - Tue Dec 09, 11:11AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 6 months, NuVasive has returned 27.77% as of today's recent price of $45.57.
NUVA: 46.99 (+0.30)
Insider Trading Alert - NUVA, MNTA And AKR Traded By Insiders
at The Street - Wed Dec 03, 9:15AM CST
Stocks with insider trader activity include NUVA, MNTA and AKR
AKR: 35.47 (-0.38), MNTA: 11.70 (-0.06), NUVA: 46.99 (+0.30)
NuVasive to Participate in Investor Event in February 2015
Marketwired - Wed Feb 04, 3:07PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive" or the "Company"
, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor event in February 2015: NUVA: 46.99 (+0.30)
30.3% Return Seen to Date on SmarTrend NuVasive Call (NUVA)
Comtex SmarTrend(R) - Thu Jan 29, 9:42AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 7 months, NuVasive has returned 30.30% as of today's recent price of $46.47.
NUVA: 46.99 (+0.30)
Downgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Tue Jan 13, 8:34AM CST
NuVasive (NASDAQ:NUVA) was downgraded from Buy to Neutral at Summer Street today. The stock closed yesterday at $49.34 on volume of 180,000 shares, below average daily volume of 342,000. In the past 52 weeks, shares of NuVasive have traded between the current low of $0.00 and a high of $51.23 and are now at $0.00. Over the past week, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 1.6%.
NUVA: 46.99 (+0.30)
New operating chief at NuVasive
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 3:13PM CST
NUVA: 46.99 (+0.30)
NuVasive Announces Expanded Leadership Roles for Executives Pat Miles and Matt Link
Marketwired - Mon Jan 12, 3:01PM CST
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive procedural solutions for spine surgery, today announced changes to its leadership team designed to enhance the Company's organizational alignment and accelerate its market share-taking strategy in the global spine market.
NUVA: 46.99 (+0.30)
NuVasive Announces Select Preliminary Unaudited Full-Year 2014 Financial Results and 2015 Outlook
Marketwired - Mon Jan 12, 3:00PM CST
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive procedural solutions for spine surgery, today provided a business and financial performance update, including the announcement of select preliminary unaudited financial results for the full-year ended December 31, 2014 and the issuance of select performance guidance for the full-year 2015.
NUVA: 46.99 (+0.30)
Global Spinal Fixation Industry Report 2015
M2 - Mon Jan 12, 6:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/vnqxn5/global_spinal) has announced the addition of the "Global Spinal Fixation Industry Report 2015" report to their offering. The Spinal Fixation Industry industry Report is a professional and in-depth study on the current state of the Spinal Fixation Industry Industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Spinal Fixation Industry market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Spinal Fixation Industry industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on the Spinal Fixation Industry industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Spinal Fixation Industry industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Spinal Fixation Industry Overview - Spinal Fixation International and China Market Analysis - Spinal Fixation Technical Data and Manufacturing Plants Analysis - Spinal Fixation Production by Regions by Technology by Applications - Spinal Fixation Manufacturing Process and Cost Structure - 2009-2014 Spinal Fixation Productions Supply Sales Demand Market Status and Forecast - Spinal Fixation Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Spinal Fixation Marketing Channels Analysis - 2015-2020 Spinal Fixation Productions Supply Sales Demand Market Status and Forecast - Spinal Fixation Industry Development Proposals - Spinal Fixation New Project Investment Feasibility Analysis - Global and China Spinal Fixation Industry Research Conclusions Companies Mentioned - A-Spine - Aesculap - Alphatec Spine Inc. - BK Meditech - Bestbio-Technical - Bonovo - ChunLi - DePuy Spine Inc. (J&J) - Dingjian Medical Instrument - Exactech Inc. - Fule Science & Technology - IRENE(Nation Medical Group) - Jiangsu IDEAL Medical Science & Technology - Kanghui Medical (Medtronic Sofamor Danek USA) - LDR Medical - Medtronic - NuVasive Inc. - PASSmed - PW MedTech - Sintea Plustek - Stryker Spine - Trauson Holding (Stryker) - WEGO - Waston - Xingang Medical Instrument - Xinrong Best Medical Instrument - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/vn...bal_spinal
ZMH: 119.33 (+1.18), MDT: 75.26 (+0.33), EXAC: 22.33 (-0.28), NUVA: 46.99 (+0.30)
Spinal Products Firm NuVasive Ripe For Expansion
at Investor's Business Daily - Thu Jan 08, 2:17PM CST
Shares of NuVasive (NUVA) moved higher in early trading on the stock market today after the maker of spinal products received an analyst upgrade that cited its potential to grab more market share, particularly internationally. In a morning research...
LDRH: 37.73 (+1.70), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45), BAX: 70.39 (+0.31), COV: 106.71 (-1.36), EW: 134.23 (+1.89), NUVA: 46.99 (+0.30)
Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Thu Jan 08, 6:54AM CST
NuVasive (NASDAQ:NUVA) was upgraded from Sector Perform to Outperform at RBC Capital today. The stock closed yesterday at $48.49 on volume of 598,000 shares, above average daily volume of 315,000. NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
NUVA: 46.99 (+0.30)
NuVasive Has Returned 33.1% Since SmarTrend Recommendation (NUVA)
Comtex SmarTrend(R) - Wed Jan 07, 11:05AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 7 months, NuVasive has returned 33.07% as of today's recent price of $47.46.
NUVA: 46.99 (+0.30)
NuVasive to Participate in Investor Event in January 2015
Marketwired - Mon Jan 05, 3:05PM CST
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor event in January 2015:
NUVA: 46.99 (+0.30)
Shares of NUVA Up 36.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 31, 9:44AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 6 months, NuVasive has returned 36.13% as of today's recent price of $48.55.
NUVA: 46.99 (+0.30)
Use of Composites in Orthopedic Industry to Reach $596 Million by 2020
PR Newswire Europe - Wed Dec 24, 3:57AM CST
NEW YORK and LONDON, December 24, 2014 /PRNewswire/ --
SNN: 35.82 (-0.28), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), NUVA: 46.99 (+0.30), SYK: 94.51 (+1.14)
NuVasive Shares Up 26.5% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Tue Dec 16, 5:09PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 6 months, NuVasive has returned 26.54% as of today's recent price of $45.13.
NUVA: 46.99 (+0.30)
Uptrend Call Working As NuVasive Stock Rises 27.8% (NUVA)
Comtex SmarTrend(R) - Tue Dec 09, 11:11AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 6 months, NuVasive has returned 27.77% as of today's recent price of $45.57.
NUVA: 46.99 (+0.30)
Insider Trading Alert - NUVA, MNTA And AKR Traded By Insiders
at The Street - Wed Dec 03, 9:15AM CST
Stocks with insider trader activity include NUVA, MNTA and AKR
AKR: 35.47 (-0.38), MNTA: 11.70 (-0.06), NUVA: 46.99 (+0.30)
